Acutus Medical, Inc.AFIBNASDAQ
Loading
| Metric | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 |
|---|---|---|---|---|---|
| Revenue Growth | -251.79% | +191.87% | -21.97% | +0.53% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | -82.10% |
| EBITDA Growth | +78.59% | +0.00% | +0.00% | +0.00% | -99.01% |
| Operating Income Growth | +112.11% | +0.00% | +0.00% | +0.00% | -100.76% |
| Net Income Growth | -323.49% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | -318.62% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | -385.93% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +2.78% | +3.23% | +2.35% | +1.83% | +1.73% |
| Weighted Average Shares Diluted Growth | -21.41% | +3.23% | +2.35% | +1.83% | +1.73% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | -49.81% | -1.92% | +20.40% | +11.37% | -30.61% |
| Inventory Growth | -67.90% | -60.58% | -66.73% | -73.35% | -58.16% |
| Asset Growth | -59.56% | -64.08% | -64.63% | -62.03% | -46.91% |
| Book Value per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Debt Growth | -0.97% | -0.72% | -7.57% | -8.09% | -7.06% |
| R&D Expense Growth | -326.99% | -100.00% | -100.00% | -100.00% | +0.00% |
| SG&A Expenses Growth | -229.29% | -25.38% | -76.03% | -68.81% | +0.00% |